Sabra Health Care REIT (SBRA) 8-KSabra Reports Fourth Quarter 2023 Results; Introduces 2024 Guidance

Exhibit 99.2

 

2 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 03 COMPANY INFORMATION 04 OVERVIEW 05 PORTFOLIO Triple-Net Portfolio Top 10 Relationships Senior Housing - Managed Portfolio Loans and Other Investments NOI Concentrations Geographic Concentrations - Consolidated Portfolio Triple-Net Lease Expirations 13 INVESTMENTS Summary 14 CAPITALIZATION Overview Indebtedness Debt Maturity Credit Metrics and Ratings 18 FINANCIAL INFORMATION 2024 Outlook Consolidated Financial Statements - Statements of Income (Loss) Consolidated Financial Statements - Balance Sheets Consolidated Financial Statements - Statements of Cash Flows FFO, Normalized FFO, AFFO and Normalized AFFO Components of Net Asset Value (NAV) 26 APPENDIX Disclaimer Reporting Definitions Discussion and Reconciliation of Certain Non-GAAP Financial Measures: CONTENT https://ir.sabrahealth.com/investors/financials/quarterly-results

 

3 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 SENIOR MANAGEMENT Rick Matros Michael Costa Talya Nevo-Hacohen Chief Executive Officer, President Chief Financial Officer, Secretary Chief Investment Officer, Treasurer and Chair and Executive Vice President and Executive Vice President Jessica Flores Chief Accounting Officer and Executive Vice President BOARD OF DIRECTORS Rick Matros Michael Foster Jeffrey Malehorn Chief Executive Officer, President Lead Independent Director Director and Chair Craig Barbarosh Lynne Katzmann Clifton Porter II Director Director Director Katie Cusack Ann Kono Director Director CONTACT INFORMATION Sabra Health Care REIT, Inc. Transfer Agent 1781 Flight Way Equiniti Trust Company, LLC Tustin, CA 92782 P.O. Box 500 888.393.8248 Newark, NJ 07101 sabrahealth.com 800.937.5449 equiniti.com COMPANY INFORMATION

 

4 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 Financial Metrics Dollars in thousands, except per share data December 31, 2023 Three Months Ended Year Ended Revenues $ 163,397 $ 647,514 Net operating income 115,944 462,013 Cash net operating income 114,085 453,163 Diluted per share data: EPS $ 0.07 $ 0.06 FFO 0.30 1.27 Normalized FFO 0.32 1.30 AFFO 0.32 1.33 Normalized AFFO 0.33 1.33 Dividends per common share 0.30 1.20 Capitalization and Market Facts Key Credit Metrics (1) December 31, 2023 December 31, 2023 Common shares outstanding 231.3 million Net Debt to Adjusted EBITDA 5.74x Common equity Market Capitalization $3.3 billion Interest Coverage 4.12x Consolidated Debt $2.4 billion Fixed Charge Coverage Ratio 4.04x Consolidated Enterprise Value $5.7 billion Total Debt/Asset Value 37 % Secured Debt/Asset Value 1 % Common stock closing price $14.27 Unencumbered Assets/Unsecured Debt 267 % Common stock 52-week range $10.08 - $14.82 Common stock ticker symbol SBRA Portfolio Dollars in thousands, units and Cash NOI reflect Sabra's pro rata share Three Months Ended December 31, 2023As of December 31, 2023 Property Count Investment Beds/Units Cash NOI Investment in Real Estate Properties, gross Triple-Net Portfolio: Skilled Nursing/Transitional Care 241 $ 3,050,861 26,769 $ 60,859 Senior Housing - Leased 43 573,274 3,473 10,219 Behavioral Health 18 496,737 1,159 10,753 Specialty Hospitals and Other 15 225,443 392 4,650 Total Triple-Net Portfolio 317 4,346,315 31,793 Senior Housing - Managed 61 1,289,485 6,041 16,067 Consolidated Real Estate Investments 378 5,635,800 37,834 Unconsolidated Joint Venture Senior Housing - Managed 16 207,310 1,256 2,425 Total Equity Investments 394 5,843,110 39,090 Investments in Loans Receivable, gross (2) 14 362,850 Preferred Equity Investments, gross (3) 5 57,849 Includes 63 relationships in 39 U.S. states and CanadaTotal Investments 413 $ 6,263,809 (1) See page 17 of this supplement for important information about these credit metrics. (2) Our loans receivable investments include one investment which has a right of first offer on six addiction treatment centers with 928 beds. (3) Our preferred equity investments include investments in entities owning four Senior Housing developments with 544 aggregate units and one Skilled Nursing/Transitional Care development with 120 beds. OVERVIEW

 

5 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 Operating Statistics (1) Twelve Months Ended September 30, 2022 December 31, 2022 March 31, 2023 June 30, 2023 September 30, 2023 Occupancy Skilled Nursing/Transitional Care 73.5 % 73.7 % 74.4 % 75.9 % 76.4 % Senior Housing - Leased 84.4 % 86.4 % 87.8 % 88.7 % 90.0 % Behavioral Health 84.0 % 83.5 % 85.9 % 83.4 % 81.1 % Specialty Hospitals and Other 77.4 % 76.9 % 76.5 % 77.2 % 79.4 % Skilled Mix Skilled Nursing/Transitional Care 34.3 % 35.0 % 34.4 % 34.9 % 34.6 % PORTFOLIO Triple-Net Portfolio (1) Occupancy Percentage and Skilled Mix (together, “Operating Statistics”) and EBITDARM Coverage for each period presented include only Stabilized Facilities owned by the Company as of the end of the quarter following the period presented and only for the duration such facilities were owned by the Company and classified as Stabilized Facilities. EBITDARM Coverage (1) Twelve Months Ended September 30, 2022 December 31, 2022 March 31, 2023 June 30, 2023 September 30, 2023 Skilled Nursing/Transitional Care 1.77x 1.63x 1.65x 1.68x 1.78x Senior Housing - Leased 1.19x 1.14x 1.15x 1.17x 1.28x Behavioral Health 1.71x 1.71x 1.87x 1.92x 1.85x Specialty Hospitals and Other 6.95x 6.40x 6.68x 6.72x 7.00x

 

6 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 PORTFOLIO Top 10 Relationships Top 10 Relationships Tenant/Borrower Credit Exposure Senior Housing - Managed Operator Exposure As of December 31, 2023 EBITDARM Coverage Twelve Months Ended (1) As of December 31, 2023 Relationship Primary Property Type Number of Sabra Investments % of Annualized Cash NOI September 30, 2023 June 30, 2023 Number of Sabra Investments % of Annualized Cash NOI Signature Healthcare Skilled Nursing 44 9.3 % 1.40x 1.30x — — The Ensign Group Skilled Nursing 31 8.2 % 2.17x 2.36x — — Avamere Family of Companies Skilled Nursing 28 7.9 % 1.83x 1.65x — — Signature Behavioral Behavioral Hospitals 5 7.0 % 1.41x 1.44x — — Recovery Centers of America Addiction Treatment 3 5.9 % N/A N/A — — Holiday AL Holdings LP Independent Living — — N/A N/A 21 5.4 % Leo Brown Group Assisted Living 5 2.9 % 1.46x 1.37x 4 2.5 % The McGuire Group Skilled Nursing 8 3.8 % 1.50x 1.33x — — CommuniCare Skilled Nursing 10 3.6 % 1.75x 1.78x — — Healthmark Group Skilled Nursing 16 3.5 % 1.34x 1.41x — — Top 10 relationships 150 52.1 % 1.58x 1.49x 25 7.9 % Remaining 53 relationships 186 31.8 % 2.67x 2.54x 52 8.2 % Total 336 83.9 % 2.06x 1.97x 77 16.1 % (1) EBITDARM Coverage is presented for Stabilized Facilities operated by the applicable tenant and is presented one quarter in arrears.

 

7 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 PORTFOLIO Senior Housing - Managed Portfolio (1) Excludes the Enlivant unconsolidated joint venture. Sabra withdrew and resigned its membership in the Enlivant Joint Venture effective May 1, 2023. (2) Same store Senior Housing - Managed portfolio includes Stabilized Facilities owned as the same property type for the full period in all comparison periods. Resident fees and services, Cash NOI and REVPOR have been adjusted for changes in the foreign currency exchange rate where applicable by applying the average exchange rate for the current period to prior period results. Operating Performance Dollars in thousands Three Months Ended December 31, 2022 March 31, 2023 June 30, 2023 September 30, 2023 December 31, 2023 Consolidated Portfolio Number of Properties 59 59 61 61 61 Number of Units 5,942 5,973 6,041 6,041 6,041 Resident fees and services $ 52,699 $ 56,721 $ 58,428 $ 59,748 $ 61,256 Cash NOI $ 13,544 $ 13,084 $ 14,464 $ 15,225 $ 16,067 Cash NOI Margin % 25.7 % 23.1 % 24.8 % 25.5 % 26.2 % Unconsolidated Portfolio (1) Number of Properties 15 16 16 16 16 Number of Units (Pro Rata) 1,011 1,258 1,258 1,256 1,256 Resident fees and services (Pro Rata) $ 6,580 $ 8,831 $ 9,760 $ 9,950 $ 10,007 Cash NOI (Pro Rata) $ 1,122 $ 2,026 $ 2,681 $ 2,612 $ 2,425 Cash NOI Margin % 17.1 % 22.9 % 27.5 % 26.3 % 24.2 % Same Store Operating Performance (2) Dollars in thousands, except REVPOR Three Months Ended December 31, 2022 March 31, 2023 June 30, 2023 September 30, 2023 December 31, 2023 Consolidated Portfolio Number of Properties 51 51 51 51 51 Number of Available Units 5,382 5,383 5,383 5,383 5,384 REVPOR AL $ 6,096 $ 6,202 $ 6,230 $ 6,256 $ 6,365 IL $ 2,690 $ 2,723 $ 2,759 $ 2,756 $ 2,773 Total $ 3,787 $ 3,849 $ 3,906 $ 3,892 $ 3,940 Occupancy AL 79.5 % 79.5 % 80.7 % 81.1 % 81.5 % IL 80.1 % 79.4 % 78.3 % 80.7 % 81.1 % Total 79.9 % 79.4 % 79.1 % 80.8 % 81.2 % Resident fees and services $ 48,878 $ 49,368 $ 49,880 $ 50,804 $ 51,687 Cash NOI $ 12,809 $ 13,300 $ 13,372 $ 14,138 $ 14,365 Cash NOI Margin % 26.2 % 26.9 % 26.8 % 27.8 % 27.8 %

 

8 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 PORTFOLIO Loans and Other Investments Loans Receivable and Other Investments Dollars in thousands As of December 31, 2023 Loan Type Number of Loans Property Type Principal Balance Book Value Weighted Average Contractual Interest Rate Weighted Average Annualized Effective Interest Rate Interest Income Three Months Ended December 31, 2023 (1) Maturity Date Mortgage 2 Behavioral Health $ 319,000 $ 319,000 7.6 % 7.6 % $ 6,111 11/01/26 - 01/31/27 Other 12 Multiple 53,873 50,440 7.7 % 7.4 % 940 10/01/23 - 05/01/29 14 372,873 369,440 7.7 % 7.6 % $ 7,051 Allowance for loan losses — (6,665) $ 372,873 $ 362,775 Other Investment Type Number of Investments Property Type Total Funding Commitments Total Amount Funded Book Value Rate of Return Other Income Three Months Ended December 31, 2023 (1) Preferred Equity 5 Skilled Nursing / Senior Housing $ 49,934 $ 49,934 $ 57,849 11.0 % $ 1,552 (1) Includes income related to loans receivable and other investments held as of December 31, 2023.

 

9 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 The Ensign Group: 8.2% Avamere Family of Companies: 7.9% Signature Behavioral: 7.0% Recovery Centers of America: 5.9% Managed (No Operator Credit Exposure): 16.1% Other: 45.6% Signature Healthcare: 9.3% RELATIONSHIP CONCENTRATION PROPERTY TYPE CONCENTRATION PAYOR SOURCE CONCENTRATION (2) PORTFOLIO NOI Concentrations (1) As of December 31, 2023 (1) Relationship and asset class concentrations include real estate investments and investments in loans receivable and other investments. Relationship concentrations use Annualized Cash NOI, and asset class concentrations use Annualized Cash NOI, as adjusted to reflect Annualized Cash NOI from our mortgage and construction loans receivable and preferred equity investments in the related asset class of the underlying real estate. Payor source concentration excludes Annualized Cash NOI from investments in loans receivable and other investments. (2) Tenant payor source allocation presented one quarter in arrears. Holiday 5.4%Sienna 3.0%Other 7.7% Behavioral Health: 14.6% Senior Housing - Leased: 10.3% Specialty Hospital and Other: 4.1% Other: 0.8% Skilled Nursing/Transitional Care: 54.1% Senior Housing - Managed: 16.1% Private Pay: 43.7% Non-Private: 56.3%

 

10 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 PORTFOLIO Geographic Concentrations - Consolidated Portfolio Property Type As of December 31, 2023 Location Skilled Nursing/ Transitional Care Senior Housing - Leased Senior Housing - Managed Consolidated    Behavioral Health Specialty Hospitals and Other Total % of Total Texas 34 5 5 — 13 57 15.1 % California 24 — 2 3 1 30 7.9 Kentucky 24 1 — 2 1 28 7.4 Indiana 14 4 1 2 — 21 5.6 Oregon 15 1 3 — — 19 5.0 North Carolina 13 — 2 — — 15 4.0 Missouri 12 — 1 1 — 14 3.7 Washington 12 — 2 — — 14 3.7 Massachusetts 12 — — — — 12 3.2 New York 9 — 1 — — 10 2.6 Other (29 states & Canada) 72 32 44 10 — 158 41.8 Total 241 43 61 18 15 378 100.0 % % of Total 63.7 % 11.4 % 16.1 % 4.8 % 4.0 % 100.0 % Distribution of Beds/Units As of December 31, 2023   Property Type Location Total Number of Properties Skilled Nursing/ Transitional Care Senior Housing - Leased Senior Housing - Managed Consolidated    Behavioral Health Specialty Hospitals and Other Total % of Total Texas 57 4,325 470 736 — 325 5,856 15.5 % Kentucky 28 2,486 142 — 172 40 2,840 7.5 California 30 2,058 — 160 313 27 2,558 6.8 Indiana 21 1,651 545 169 138 — 2,503 6.6 Oregon 19 1,520 215 162 — — 1,897 5.0 North Carolina 15 1,454 — 237 — — 1,691 4.5 New York 10 1,566 — 107 — — 1,673 4.4 Washington 14 1,309 — 165 — — 1,474 3.9 Massachusetts 12 1,469 — — — — 1,469 3.9 Virginia 10 894 60 186 — — 1,140 3.0 Other (29 states & Canada) 162 8,037 2,041 4,119 536 — 14,733 38.9 Total 378 26,769 3,473 6,041 1,159 392 37,834 100.0 % % of Total 70.7 % 9.2 % 16.0 % 3.1 % 1.0 % 100.0 %

 

11 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 PORTFOLIO Geographic Concentrations - Consolidated Portfolio Continued Investment Dollars in thousands As of December 31, 2023   Property Type Location Total Number of Properties Skilled Nursing/ Transitional Care Senior Housing - Leased Senior Housing - Managed Consolidated    Behavioral Health Specialty Hospitals and Other    Total % of Total Texas 57 $ 347,245 $ 55,818 $ 173,043 $ — $ 187,387 $ 763,493 13.5 % California 30 435,612 — 59,434 217,764 7,743 720,553 12.8 Indiana 21 196,544 120,197 47,861 12,155 — 376,757 6.7 Oregon 19 261,316 33,002 54,214 — — 348,532 6.2 New York 10 298,004 — 20,688 — — 318,692 5.8 Kentucky 28 244,385 23,668 — 15,165 30,313 313,531 5.6 Washington 14 158,674 — 41,142 — — 199,816 3.5 North Carolina 15 124,449 — 75,251 — — 199,700 3.5 Arizona 5 — 10,348 39,656 121,757 — 171,761 3.0 Canada (1) 9 — — 159,550 — — 159,550 2.8 Other (30 states) 170 984,632 330,241 618,646 129,896 — 2,063,415 36.6 Total 378 $ 3,050,861 $ 573,274 $ 1,289,485 $ 496,737 $ 225,443 $ 5,635,800 100.0 % % of Total 54.1 % 10.2 % 22.9 % 8.8 % 4.0 % 100.0 % (1) Investment balance in Canada is based on the exchange rate as of December 31, 2023 of $0.7546 per 1 CAD.

 

12 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 PORTFOLIO Triple-Net Lease Expirations Triple-Net Lease Expirations Dollars in thousands Skilled Nursing/ Transitional Care Senior Housing - Leased Behavioral Health Specialty Hospitals and Other Total Annualized RevenuesAs of December 31, 2023   % of Total 2024 $ 6,276 $ — $ — $ — $ 6,276 1.8 % 2025 6,311 2,515 — 1,495 10,321 2.9 % 2026 16,834 1,242 — — 18,076 5.1 % 2027 24,308 4,237 — — 28,545 8.1 % 2028 20,964 6,205 — 3,490 30,659 8.7 % 2029 47,705 4,907 — 6,138 58,750 16.7 % 2030 — — — 3,158 3,158 0.9 % 2031 68,811 5,601 1,558 — 75,970 21.5 % 2032 5,785 1,667 32,821 3,749 44,022 12.5 % 2033 — 3,015 5,311 — 8,326 2.4 % Thereafter 52,121 12,472 3,071 746 68,410 19.4 % Total Annualized Revenues $ 249,115 $ 41,861 $ 42,761 $ 18,776 $ 352,513 100.0 %

 

13 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 INVESTMENTS Summary Investment Activity Dollars in thousands Investment Initial Investment Date Property Type Number of Properties Beds/Units 2023 Amounts Invested (1) Expected Cash Yield Real Estate Traditions at Camargo (2) 02/01/23 Senior Housing - Managed 1 151 $ 48,025 8.00 % Wickshire Norman 02/01/23 Senior Housing - Leased 1 70 3,250 8.00 % Ignite Medical Resort Portfolio 11/01/23 Skilled Nursing/ Transitional Care 2 228 38,770 9.50 % Additions to Real Estate (3) Various Multiple N/A N/A 34,342 8.70 % Total Real Estate Investments 124,387 8.66 % Unconsolidated Joint Venture Marlin Spring Joint Venture (4) 02/20/23 Senior Housing - Managed 1 290 18,939 8.00 % Preferred Equity Preferred Equity Fundings Various Multiple N/A N/A 11,018 11.93 % Loans Receivable Loans Receivable Fundings Various Multiple N/A N/A 11,755 9.29 % All Investments through December 31, 2023 $ 166,099 8.85 % (1) Excludes capitalized acquisition costs and origination fees. (2) Amount invested reflects the gross investment, of which $4.6 million was used to repay our preferred equity investment. (3) Excludes capital expenditures for the Senior Housing - Managed portfolio and recurring capital expenditures for the Triple-Net portfolio. (4) Amount invested relates to the acquisition of one additional property and reflects Sabra's 85% pro rata share of the gross investment of CAD $30.0 million and is based on the exchange rate as of the investment date. In addition, the Marlin Spring Joint Venture financed and assumed an aggregate CAD $23.6 million of debt associated with this additional acquisition. Sabra's equity investment in the additional property was CAD $6.1 million.

 

14 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 CAPITALIZATION Overview Consolidated Debt Dollars in thousands As of December 31, 2023 Secured debt $ 48,143 Revolving credit facility 94,429 Term loans 543,190 Senior unsecured notes 1,750,000 Total 2,435,762 Deferred financing costs and premiums/discounts, net (21,659) Total, net $ 2,414,103 Revolving Credit Facility Dollars in thousands As of December 31, 2023 Credit facility availability $ 905,571 Credit facility capacity 1,000,000 Enterprise Value Dollars in thousands, except per share amounts As of December 31, 2023 Shares Outstanding   Price   Value Common stock 231,266,020 $ 14.27 $ 3,300,166 Consolidated Debt 2,435,762 Cash and cash equivalents (41,285) Consolidated Enterprise Value $ 5,694,643 Common Stock and Equivalents Weighted Average Common Shares Three Months Ended December 31, 2023 Year Ended December 31, 2023 EPS, FFO and Normalized FFO AFFO and Normalized AFFO EPS, FFO and Normalized FFO AFFO and Normalized AFFO Common stock 231,220,028 231,220,028 231,198,579 231,198,579 Common equivalents 4,812 4,812 4,812 4,812 Basic common and common equivalents 231,224,840 231,224,840 231,203,391 231,203,391 Dilutive securities: Restricted stock units 1,975,340 2,796,932 1,589,387 2,679,888 Diluted common and common equivalents 233,200,180 234,021,772 232,792,778 233,883,279

 

15 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 CAPITALIZATION Indebtedness Fixed | Variable Rate Debt Dollars in thousands Weighted Average Effective Interest Rate (1)As of December 31, 2023 Principal     % of Total Fixed Rate Debt   Secured debt $ 48,143     3.34 %   2.0 % Senior unsecured notes 1,750,000     4.04 %   71.8 % Total fixed rate debt 1,798,143     4.02 %   73.8 % Variable Rate Debt (2)   Revolving credit facility 94,429     6.57 %   3.9 % Term loans 543,190 3.72 % 22.3 % Total variable rate debt 637,619     4.14 %   26.2 % Consolidated Debt $ 2,435,762     4.05 %   100.0 % Secured | Unsecured Debt Dollars in thousands Weighted Average Effective Interest Rate (1)As of December 31, 2023 Principal     % of Total Secured Debt   Secured debt $ 48,143     3.34 %   2.0 % Unsecured Debt Senior unsecured notes 1,750,000     4.04 %   71.8 % Revolving credit facility 94,429     6.57 %   3.9 % Term loans 543,190 3.72 % 22.3 % Total unsecured debt 2,387,619     4.07 %   98.0 % Consolidated Debt $ 2,435,762     4.05 %   100.0 % (1) Weighted average effective interest rate includes private mortgage insurance and impact of interest rate hedges. (2) Variable rate debt includes $430.0 million subject to interest rate swaps and interest rate collars that fix and set a cap and floor, respectively, for SOFR at a weighted average rate of 2.69%, and $113.2 million (CAD $150.0 million) subject to swap agreements that fix CDOR at 1.63% as of December 31, 2023. Excluding these amounts, variable rate debt was 3.9% of Consolidated Debt as of December 31, 2023.

 

16 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 CAPITALIZATION Debt Maturity Debt Maturity Schedule Dollars in thousands Secured Debt Senior Unsecured Notes   Term Loans     Revolving Credit Facility (1) Consolidated Debt As of December 31, 2023 Principal Rate (2) Principal Rate (2)   Principal Rate (2)     Principal Rate (2) Principal Rate (2) 2024 $ 2,033   2.85 %   $ —   —     $ —   —     $ — — $ 2,033   2.85 % 2025 2,089   2.86 %   —   —     —   —     — — 2,089   2.86 % 2026 2,147   2.86 %   500,000   5.13 %     —   —     — — 502,147   5.12 % 2027 2,206   2.87 %   100,000   5.88 % —   —     94,429 6.57 % 196,635   6.18 % 2028 2,266   2.88 %   —   — 543,190   6.72 %     — — 545,456   6.71 % 2029 2,328   2.89 %   350,000   3.90 %     —   —     — — 352,328   3.89 % 2030 2,392   2.90 %   — — —   —     — — 2,392   2.90 % 2031 2,093   2.92 %   800,000   3.20 %     —   —     — — 802,093   3.20 % 2032 1,887   2.92 %   —   —     —   —     — — 1,887   2.92 % 2033 1,940   2.93 % — — — — — — 1,940 2.93 % Thereafter 26,762   3.10 %   —   —     —   —     — — 26,762   3.10 % Total 48,143   1,750,000 543,190     94,429 2,435,762 Discount, net — (4,258) — — (4,258) Deferred financing costs, net (842) (10,489) (6,070) — (17,401) Total, net $ 47,301 $ 1,735,253 $ 537,120     $ 94,429 $ 2,414,103 Wtd. avg. maturity/years 21.0   5.7 4.0     3.0 5.5 Wtd. avg. interest rate (3) 3.34 %   4.04 % 3.72 %     6.57 % 4.05 % (1) Revolving Credit Facility is subject to two six-month extension options. (2) Represents actual contractual interest rates excluding private mortgage insurance and impact of interest rate hedges. (3) Weighted average interest rate includes private mortgage insurance and impact of interest rate hedges.

 

17 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 Key Credit Metrics (1) December 31, 2023 Net Debt to Adjusted EBITDA (2) 5.74x Interest Coverage (2) 4.12x Fixed Charge Coverage Ratio (2) 4.04x Total Debt/Asset Value 37 % Secured Debt/Asset Value 1 % Unencumbered Assets/Unsecured Debt 267 % Cost of Permanent Consolidated Debt (3) 3.95 % Unsecured Notes Ratings S&P (Stable outlook) BBB- Fitch (Stable outlook) BBB- Moody's (Stable outlook) Ba1 CAPITALIZATION Credit Metrics and Ratings (1) Key credit statistics (except Net Debt to Adjusted EBITDA) are calculated in accordance with the credit agreement relating to the revolving credit facility and the indentures relating to our senior unsecured notes. In addition, key credit statistics give effect to dispositions and acquisitions completed after the period presented as though such dispositions and acquisitions occurred at the beginning of the period. (2) Based on the trailing twelve-month period ended as of the date indicated. (3) Excludes revolving credit facility balance that had an interest rate of 6.57% as of December 31, 2023.

 

18 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 2024 Full-Year Guidance   Diluted per share data Net income $ 0.53 — $ 0.57 FFO $ 1.33 — $ 1.37 Normalized FFO $ 1.34 — $ 1.38 AFFO $ 1.38 — $ 1.42 Normalized AFFO $ 1.39 — $ 1.43 FINANCIAL INFORMATION 2024 Outlook Earnings guidance above assumes no 2024 acquisition or disposition activity.

 

19 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 FINANCIAL INFORMATION Consolidated Financial Statements Consolidated Statements of Income (Loss) Dollars in thousands, except per share data Three Months Ended December 31, Year Ended December 31,   2023 2022 2023 2022 Revenues: Rental and related revenues (1) $ 93,037 $ 103,318 $ 376,266 $ 400,586 Resident fees and services 61,256 52,699 236,153 186,672 Interest and other income 9,104 8,968 35,095 37,553       Total revenues 163,397 164,985 647,514 624,811     Expenses: Depreciation and amortization 42,876 49,927 183,087 187,782 Interest 27,940 27,898 112,964 105,471 Triple-net portfolio operating expenses 4,689 4,640 17,932 19,623 Senior housing - managed portfolio operating expenses 45,189 39,155 177,313 142,990 General and administrative 16,679 10,853 47,472 39,574 (Recovery of) provision for loan losses and other reserves (358) 153 191 141 Impairment of real estate 7,268 21,440 14,332 94,042       Total expenses 144,283 154,066 553,291 589,623     Other (expense) income: Loss on extinguishment of debt — — (1,541) (411) Other income (expense) 28 4 2,598 (1,097) Net loss on sales of real estate (732) (7,430) (76,625) (12,011) Total other expense (704) (7,426) (75,568) (13,519) Income before loss from unconsolidated joint ventures and income tax expense 18,410 3,493 18,655 21,669 Loss from unconsolidated joint ventures (761) (88,317) (2,897) (98,032) Income tax expense (493) (124) (2,002) (1,242) Net income (loss) $ 17,156 $ (84,948) $ 13,756 $ (77,605)     Net income (loss), per: Basic common share $ 0.07 $ (0.37) $ 0.06 $ (0.34)         Diluted common share $ 0.07 $ (0.37) $ 0.06 $ (0.34)         Weighted average number of common shares outstanding, basic 231,224,840 230,986,260 231,203,391 230,947,895   Weighted average number of common shares outstanding, diluted 233,200,180 230,986,260 232,792,778 230,947,895 (1) See page 20 for additional details regarding Rental and related revenues.

 

20 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 FINANCIAL INFORMATION Consolidated Financial Statements Consolidated Statements of Income (Loss) - Supplemental Information Dollars in thousands Three Months Ended December 31, Year Ended December 31,   2023 2022 2023 2022 Cash rental income $ 87,233 $ 96,501 $ 352,277 $ 385,033 Straight-line rental income 1,693 1,219 5,392 8,261 Straight-line rental income receivable write-offs (1,004) — (2,514) (17,068) Above/below market lease amortization 1,229 1,569 5,821 6,299 Above/below market lease intangible write-offs — — — 326 Operating expense recoveries 3,886 4,029 15,290 17,735 Rental and related revenues $ 93,037 $ 103,318 $ 376,266 $ 400,586

 

21 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 FINANCIAL INFORMATION Consolidated Financial Statements Consolidated Balance Sheets Dollars in thousands, except per share data December 31, 2023 December 31, 2022   (unaudited)   Assets Real estate investments, net of accumulated depreciation of $1,021,086 and $913,345 as of December 31, 2023 and December 31, 2022, respectively $ 4,617,261 $ 4,959,343 Loans receivable and other investments, net 420,624 411,396 Investment in unconsolidated joint ventures 136,843 134,962 Cash and cash equivalents 41,285 49,308 Restricted cash 5,434 4,624 Lease intangible assets, net 30,897 40,131 Accounts receivable, prepaid expenses and other assets, net 133,806 147,908 Total assets $ 5,386,150 $ 5,747,672 Liabilities Secured debt, net $ 47,301 $ 49,232 Revolving credit facility 94,429 196,982 Term loans, net 537,120 526,129 Senior unsecured notes, net 1,735,253 1,734,431 Accounts payable and accrued liabilities 136,981 142,259 Lease intangible liabilities, net 32,532 42,244 Total liabilities 2,583,616 2,691,277 Equity Preferred stock, $0.01 par value; 10,000,000 shares authorized, zero shares issued and outstanding as of December 31, 2023 and December 31, 2022 — — Common stock, $0.01 par value; 500,000,000 shares authorized, 231,266,020 and 231,009,295 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively 2,313 2,310 Additional paid-in capital 4,494,755 4,486,967 Cumulative distributions in excess of net income (1,718,279) (1,451,945) Accumulated other comprehensive income 23,745 19,063 Total equity 2,802,534 3,056,395 Total liabilities and equity $ 5,386,150 $ 5,747,672

 

22 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 FINANCIAL INFORMATION Consolidated Financial Statements Consolidated Statements of Cash Flows Dollars in thousands Year Ended December 31, 2023 2022 Cash flows from operating activities: Net income (loss) $ 13,756 $ (77,605) Adjustments to reconcile net income (loss) to net cash provided by operating activities: Depreciation and amortization 183,087 187,782 Non-cash rental and related revenues (8,699) 2,183 Non-cash interest income (372) (2,285) Non-cash interest expense 12,265 11,094 Stock-based compensation expense 7,917 7,453 Loss on extinguishment of debt 1,541 411 Provision for loan losses and other reserves 191 141 Net loss on sales of real estate 76,625 12,011 Impairment of real estate 14,332 94,042 Other-than-temporary impairment of unconsolidated joint ventures — 57,778 Loss from unconsolidated joint ventures 2,897 40,254 Distributions of earnings from unconsolidated joint ventures 3,469 — Other non-cash items (3,704) 2,167 Changes in operating assets and liabilities: Accounts receivable, prepaid expenses and other assets, net (11,078) (6,443) Accounts payable and accrued liabilities 8,344 (13,250) Net cash provided by operating activities 300,571 315,733 Cash flows from investing activities: Acquisition of real estate (78,530) (92,204) Origination and fundings of loans receivable (11,418) (23,812) Origination and fundings of preferred equity investments (11,023) (8,021) Additions to real estate (84,855) (54,473) Escrow deposits for potential investments — (780) Repayments of loans receivable 9,274 5,272 Repayments of preferred equity investments 5,460 5,376 Investment in unconsolidated joint ventures (5,235) (142,910) Net proceeds from the sales of real estate 247,622 87,304 Net proceeds from sales-type lease 25,490 — Deposits for potential sale of real estate — 8,000 Insurance proceeds 5,801 — Distributions in excess of earnings from unconsolidated joint ventures 544 — Net cash provided by (used in) investing activities 103,130 (216,248) Cash flows from financing activities: Net (repayments of) borrowings from revolving credit facility (104,338) 204,046 Proceeds from term loans 12,188 — Principal payments on term loans — (63,750) Principal payments on secured debt (1,979) (17,516) Payments of deferred financing costs (18,142) (20) Payment of contingent consideration (17,900) (2,500) Issuance of common stock, net (2,682) (4,810) Dividends paid on common stock (277,447) (277,157) Net cash used in financing activities (410,300) (161,707) Net decrease in cash, cash equivalents and restricted cash (6,599) (62,222) Effect of foreign currency translation on cash, cash equivalents and restricted cash (614) 268 Cash, cash equivalents and restricted cash, beginning of period 53,932 115,886 Cash, cash equivalents and restricted cash, end of period $ 46,719 $ 53,932

 

23 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 FINANCIAL INFORMATION Consolidated Financial Statements Consolidated Statements of Cash Flows (Continued) Dollars in thousands Year Ended December 31, 2023 2022 Supplemental disclosure of cash flow information: Interest paid $ 102,409 $ 97,723 Income taxes paid $ 1,670 $ 1,657 Supplemental disclosure of non-cash investing activities: Decrease in loans receivable and other investments due to acquisition of real estate $ 4,644 $ 14,311

 

24 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 FINANCIAL INFORMATION FFO, Normalized FFO, AFFO and Normalized AFFO (1) Funding for support payments did not require capital contributions from Sabra but rather were funded with proceeds received by our Enlivant unconsolidated joint venture from TPG for the issuance of senior preferred interests. (2) Other normalizing items for FFO and AFFO for the three months ended December 31, 2023 include a $3.8 million catch-up adjustment related to changes in performance-based assumptions on management's compensation. Other normalizing items for FFO and AFFO for the year ended December 31, 2023 include $3.7 million of gain on insurance proceeds and $1.6 million of transition expenses related to the transition of 14 Senior Housing - Managed communities to new operators. Other normalizing items for FFO for the year ended December 31, 2022 include $2.2 million of foreign currency transaction loss related to our Canadian borrowings. In addition, other normalizing items for FFO and AFFO include triple-net operating expenses, net of recoveries and certain adjustments for amounts recorded in the current period that relate to a prior period. (3) Other adjustments for the year ended December 31, 2022 includes $2.2 million of foreign currency transaction loss related to our Canadian borrowings. FFO, Normalized FFO, AFFO and Normalized AFFO Dollars in thousands, except per share data Three Months Ended December 31, Year Ended December 31,   2023 2022 2023 2022 Net income (loss) $ 17,156 $ (84,948) $ 13,756 $ (77,605) Add: Depreciation and amortization of real estate assets 42,876 49,927 183,087 187,782 Depreciation, amortization and impairment of real estate assets related to unconsolidated joint ventures 2,192 6,239 8,697 22,095 Net loss on sales of real estate 732 7,430 76,625 12,011 Net gain on sales of real estate related to unconsolidated joint ventures — — — (220) Impairment of real estate 7,268 21,440 14,332 94,042 Other-than-temporary impairment of unconsolidated joint ventures — 57,778 — 57,778 FFO $ 70,224 $ 57,866 $ 296,497 $ 295,883 Write-offs of cash and straight-line rental income receivable and lease intangibles 1,030 — 2,519 15,831 Lease termination income — (139) — (2,477) Loss on extinguishment of debt — — 1,541 411 (Recovery of) provision for loan losses and other reserves (358) 153 191 141 Deferred tax valuation allowance related to unconsolidated joint ventures — 19,613 — 19,613 Support payments paid to joint venture manager (1) — 6,370 — 12,250 Other normalizing items (2) 4,551 842 1,546 3,428 Normalized FFO $ 75,447 $ 84,705 $ 302,294 $ 345,080 FFO $ 70,224 $ 57,866 $ 296,497 $ 295,883 Stock-based compensation expense 2,449 2,086 7,917 7,453 Non-cash rental and related revenues (1,918) (2,787) (8,699) 2,183 Non-cash interest income 8 (602) (372) (2,285) Non-cash interest expense 3,086 2,794 12,265 11,094 Non-cash portion of loss on extinguishment of debt — — 1,541 411 (Recovery of) provision for loan losses and other reserves (358) 153 191 141 Deferred tax valuation allowance related to unconsolidated joint ventures — 19,613 — 19,613 Other adjustments related to unconsolidated joint ventures 131 (1,099) 502 (5,155) Other adjustments (3) 141 44 365 2,474 AFFO $ 73,763 $ 78,068 $ 310,207 $ 331,812 Cash portion of lease termination income — (139) — (2,477) Write-off of cash rental income — — — 71 Support payments paid to joint venture manager (1) — 6,370 — 12,250 Other normalizing items (2) 4,536 827 1,485 1,077 Normalized AFFO $ 78,299 $ 85,126 $ 311,692 $ 342,733 Amounts per diluted common share: Net income (loss) $ 0.07 $ (0.37) $ 0.06 $ (0.34) FFO $ 0.30 $ 0.25 $ 1.27 $ 1.28 Normalized FFO $ 0.32 $ 0.37 $ 1.30 $ 1.49 AFFO $ 0.32 $ 0.34 $ 1.33 $ 1.43 Normalized AFFO $ 0.33 $ 0.37 $ 1.33 $ 1.47 Weighted average number of common shares outstanding, diluted: Net income (loss) 233,200,180 230,986,260 232,792,778 230,947,895 FFO and Normalized FFO 233,200,180 232,059,703 232,792,778 231,851,542 AFFO and Normalized AFFO 234,021,772 232,868,137 233,883,279 232,784,543

 

25 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 FINANCIAL INFORMATION Components of Net Asset Value (NAV) As of December 31, 2023 (1) Amounts represent principal amounts due and exclude deferred financing costs, net and premiums/discounts, net. (2) Includes balances that impact cash or NOI and excludes non-cash items. Annualized Cash NOI Dollars in thousands Skilled Nursing/Transitional Care $ 249,115 Senior Housing - Leased 41,861 Senior Housing - Managed Consolidated Portfolio 64,482 Senior Housing - Managed Unconsolidated Portfolio 9,702 Behavioral Health 42,761 Specialty Hospitals and Other 18,776 Annualized Cash NOI (excluding loans receivable and other investments) $ 426,697 Obligations Dollars in thousands Secured debt (1) $ 48,143 Senior unsecured notes (1) 1,750,000 Revolving credit facility 94,429 Term loans (1) 543,190 Sabra’s share of unconsolidated joint venture debt 74,673 Total Debt 2,510,435 Add (less): Cash and cash equivalents and restricted cash (46,719) Sabra’s share of unconsolidated joint venture cash and cash equivalents and restricted cash (3,806) Accounts payable and accrued liabilities (2) 122,469 Net obligations $ 2,582,379 Other Assets Dollars in thousands Loans receivable and other investments, net $ 420,624 Accounts receivable, prepaid expenses and other assets, net (2) 28,818 Total other assets $ 449,442 Common Shares Outstanding Total shares 231,266,020 We disclose components of our business relevant to calculate NAV. We consider NAV to be a useful supplemental measure that assists both management and investors to estimate the fair value of our Company. The calculation of NAV involves significant estimates and can be calculated using various methods. Each individual investor must determine the specific methodology, assumptions and estimates to use to arrive at an estimated NAV of the Company. The components of NAV do not consider potential changes in our investment portfolio. The components include non-GAAP financial measures, such as Cash NOI. Although these measures are not presented in accordance with GAAP, investors can use these non-GAAP financial measures as supplemental information to evaluate our business.

 

26 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 APPENDIX Disclaimer Disclaimer This supplement contains “forward-looking” information as that term is defined in the Private Securities Litigation Reform Act of 1995. Any statements that do not relate to historical or current facts or matters are forward-looking statements. Examples of forward-looking statements include all statements regarding our expected future financial position (including our earnings guidance for 2024, as well as the assumptions set forth therein), results of operations, cash flows, liquidity, business strategy, growth opportunities, potential investments, and plans and objectives for future operations. You can identify some of the forward-looking statements by the use of forward-looking words such as "anticipate," "believe," "plan," "estimate," "expect," "intend," "should," "may" and other similar expressions, although not all forward-looking statements contain these identifying words. Our actual results may differ materially from those projected or contemplated by our forward-looking statements as a result of various factors, including, among others, the following: increased labor costs and historically low unemployment; increases in market interest rates and inflation; pandemics or epidemics, including COVID-19, and the related impact on our tenants, borrowers and Senior Housing - Managed communities; operational risks with respect to our Senior Housing - Managed communities; competitive conditions in our industry; the loss of key management personnel; uninsured or underinsured losses affecting our properties; potential impairment charges and adjustments related to the accounting of our assets; the potential variability of our reported rental and related revenues as a result of Accounting Standards Update (“ASU”) 2016-02, Leases, as amended by subsequent ASUs; risks associated with our investment in our unconsolidated joint ventures; catastrophic weather and other natural or man-made disasters, the effects of climate change on our properties and a failure to implement sustainable and energy-efficient measures; increased operating costs and competition for our tenants, borrowers and Senior Housing - Managed communities; increased healthcare regulation and enforcement; our tenants’ dependency on reimbursement from governmental and other third-party payor programs; the effect of our tenants, operators or borrowers declaring bankruptcy or becoming insolvent; our ability to find replacement tenants and the impact of unforeseen costs in acquiring new properties; the impact of litigation and rising insurance costs on the business of our tenants; the impact of required regulatory approvals of transfers of healthcare properties; environmental compliance costs and liabilities associated with real estate properties we own; our tenants’, borrowers' or operators’ failure to adhere to applicable privacy and data security laws, or a material breach of our or our tenants’, borrowers' or operators’ information technology; our concentration in the healthcare property sector, particularly in skilled nursing/transitional care facilities and senior housing communities, which makes our profitability more vulnerable to a downturn in a specific sector than if we were investing in multiple industries; the significant amount of and our ability to service our indebtedness; covenants in our debt agreements that may restrict our ability to pay dividends, make investments, incur additional indebtedness and refinance indebtedness on favorable terms; adverse changes in our credit ratings; our ability to make dividend distributions at expected levels; our ability to raise capital through equity and debt financings; changes and uncertainty in macroeconomic conditions and disruptions in the financial markets; risks associated with our ownership of property outside the U.S., including currency fluctuations; the relatively illiquid nature of real estate investments; our ability to maintain our status as a real estate investment trust (“REIT”) under the federal tax laws; compliance with REIT requirements and certain tax and tax regulatory matters related to our status as a REIT; changes in tax laws and regulations affecting REITs; the ownership limits and takeover defenses in our governing documents and under Maryland law, which may restrict change of control or business combination opportunities; and the exclusive forum provisions in our bylaws. Additional information concerning risks and uncertainties that could affect our business can be found in our filings with the Securities and Exchange Commission (the “SEC”), including in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2023. We do not intend, and we undertake no obligation, to update any forward-looking information to reflect events or circumstances after the date of this supplement or to reflect the occurrence of unanticipated events, unless required by law to do so. Note Regarding Non-GAAP Financial Measures This supplement includes the following financial measures defined as non-GAAP financial measures by the SEC: net operating income (“NOI”), Cash NOI, funds from operations (“FFO”), Normalized FFO, Adjusted FFO (“AFFO”), Normalized AFFO, FFO per diluted common share, Normalized FFO per diluted common share, AFFO per diluted common share, Normalized AFFO per diluted common share and Adjusted EBITDA (defined below). These measures may be different than non-GAAP financial measures used by other companies, and the presentation of these measures is not intended to be considered in isolation or as a substitute for financial information prepared and presented in accordance with U.S. generally accepted accounting principles. An explanation of these non-GAAP financial measures is included under “Reporting Definitions” in this supplement and reconciliations of these non-GAAP financial measures to the GAAP financial measures we consider most comparable are included on the Investors section of our website at https://ir.sabrahealth.com/investors/ financials/quarterly-results. Tenant and Borrower Information This supplement includes information regarding our tenants that lease properties from us and our borrowers, most of which are not subject to SEC reporting requirements. The information related to our tenants and borrowers that is provided in this supplement has been provided by, or derived from information provided by, such tenants and borrowers. We have not independently verified this information. We have no reason to believe that such information is inaccurate in any material respect. We are providing this data for informational purposes only. Sabra Information The information in this supplemental information package should be read in conjunction with the Company's Annual Report on Form 10- K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other information filed with the SEC. The Reporting Definitions and Reconciliations of Non-GAAP Measures are an integral part of the information presented herein. On Sabra’s website, www.sabrahealth.com, you can access, free of charge, Sabra's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, as soon as reasonably practicable after such material is filed with, or furnished to, the SEC. The information contained on Sabra’s website is not incorporated by reference into, and should not be considered a part of, this supplemental information package. All material filed with the SEC can also be accessed through its website, www.sec.gov. For more information, contact Investor Relations at (888) 393-8248 or investorrelations@sabrahealth.com.

 

27 SABRA 4Q 2023 SUPPLEMENTAL INFORMATION December 31, 2023 APPENDIX Reporting Definitions Adjusted EBITDA* Adjusted EBITDA is calculated as earnings before interest, taxes, depreciation and amortization (“EBITDA”) excluding the impact of merger-related costs, stock-based compensation expense under the Company's long-term equity award program, and loan loss reserves. Adjusted EBITDA is an important non-GAAP supplemental measure of operating performance. Annualized Cash Net Operating Income (“Annualized Cash NOI”)* The Company believes that net income as defined by GAAP is the most appropriate earnings measure. The Company considers Annualized Cash NOI an important supplemental measure because it allows investors, analysts and its management to evaluate the operating performance of its investments. The Company defines Annualized Cash NOI as Annualized Revenues less operating expenses and non-cash revenues and expenses. Annualized Cash NOI excludes all other financial statement amounts included in net income. Annualized Revenues  The annual contractual rental revenues under leases and interest and other income generated by the Company’s loans receivable and other investments based on amounts invested and applicable terms as of the end of the period presented. Annualized Revenues do not include tenant recoveries or additional rents and are adjusted to reflect actual payments received related to the twelve months ended at the end of the respective period for leases no longer accounted for on an accrual basis. Behavioral Health Includes behavioral hospitals that provide inpatient and outpatient care for patients with mental health conditions, chemical dependence or substance addictions and addiction treatment centers that provide treatment services for chemical dependence and substance addictions, which may include inpatient care, outpatient care, medical detoxification, therapy and counseling. Cash Net Operating Income (“Cash NOI”)*    The Company believes that net income as defined by GAAP is the most appropriate earnings measure. The Company considers Cash NOI an important supplemental measure because it allows investors, analysts and its management to evaluate the operating performance of its investments. The Company defines Cash NOI as total revenues less operating expenses and non-cash revenues and expenses. Cash NOI excludes all other financial statement amounts included in net income. Cash NOI Margin Cash NOI Margin is calculated as Cash NOI divided by resident fees and services. Consolidated Debt  The principal balances of the Company’s revolving credit facility, term loans, senior unsecured notes, and secured indebtedness as reported in the Company’s consolidated financial statements. Consolidated Debt, Net The carrying amount of the Company’s revolving credit facility, term loans, senior unsecured notes, and secured indebtedness, as reported in the Company’s consolidated financial statements. Consolidated Enterprise Value The Company believes Consolidated Enterprise Value is an important measurement as it is a measure of a company’s value. The Company calculates Consolidated Enterprise Value as market equity capitalization plus Consolidated Debt. Market equity capitalization is calculated as (i) the number of shares of common stock multiplied by the closing price of the Company’s common stock on the last day of the period presented plus (ii) the number of shares of preferred stock multiplied by the closing price of the Company’s preferred stock on the last day of the period presented. Consolidated Enterprise Value includes the Company’s market equity capitalization and Consolidated Debt, less cash and cash equivalents. EBITDARM  Earnings before interest, taxes, depreciation, amortization, rent and management fees (“EBITDARM”) for a particular facility accruing to the operator/tenant of the property (not the Company), for the period presented. The Company uses EBITDARM in determining EBITDARM Coverage. EBITDARM has limitations as an analytical tool. EBITDARM does not reflect historical cash expenditures or future cash requirements for facility capital expenditures or contractual commitments. In addition, EBITDARM does not represent a property’s net income or cash flows from operations and should not be considered an alternative to those indicators. The Company utilizes EBITDARM to evaluate the core operations of the properties by eliminating management fees, which may vary by operator/tenant and operating structure, and as a supplemental measure of the ability of the Company’s operators/tenants and relevant guarantors to generate sufficient liquidity to meet related obligations to the Company. EBITDARM Coverage  Represents the ratio of EBITDARM to cash rent for owned facilities (excluding Senior Housing - Managed communities) for the period presented. EBITDARM Coverage is a supplemental measure of a property’s ability to generate cash flows for the operator/tenant (not the Company) to meet the operator’s/tenant’s related cash rent and other obligations to the Company. However, its usefulness is limited by, among other things, the same factors that limit the usefulness of EBITDARM. EBITDARM Coverage includes only Stabilized Facilities and excludes facilities for which data is not available or meaningful.